UTILITY therapeutics Ltd., a biotechnology company focused on the U.S. development and commercialization of two European-approved antibiotics for the treatment of urinary tract infections (UTI, to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections. The World Health Organisation has stated that antibiotic resistance is one of the biggest threats to global health, food security, and development today. Pivmecillinam is an oral prodrug of mecillinam that is being developed for uncomplicated UTI (uUTI), and it has a unique mechanism of action for infections caused by Gram-negative bacteria, including extended-spectrum beta-lactamases. Mecillinam, an intravenous (IV) formulation, is being developed as a first-line therapy for complicated UTI (cUTI) in the hospital setting.
| Website | https://utilitytherapeutics.com/ |
| Employees | 2 (0 on RocketReach) |
| Founded | 2017 |
| Address | 1 Ashley Road, Altrincham, England WA14 2DT, GB |
| Phone | +44 20 3930 9665 |
| Technologies |
JavaScript
,
HTML
,
PHP
+7 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Life Science |
| Keywords | Urinary Tract Infection, Uti Treatment, Antibiotics, New Antibiotics, Infection Treatment, Drug Development, Drug Commercialization, Antibacterial, Pharmaceutical, Therapeutic Solutions, Pharmaceutical Development, Biotechnology, Healthcare, Drug Discovery, Clinical Development, Antimicrobial Resistance, Fda Approval |
| Competitors | Thermo Fisher Scientific, Amgen, Regeneron, Vertex Pharmaceuticals, Moderna Therapeutics, Alnylam Pharmaceuticals, Lengo Therapeutics, Sorrento Therapeutics, Inc., AnaptysBio, Alder BioPharmaceuticals, Inc. +38 more (view full list) |
Looking for a particular UTILITY therapeutics employee's phone or email?
UTILITY therapeutics Questions
UTILITY therapeutics is based in Altrincham, England.
